Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting?. Anaphylaxis as a case study

Vaccine

Volumn 28, Issue 28, 2010, Pages 4487-4498

  Gold, Michael S ^a   Gidudu, Jane ^b   Erlewyn Lajeunesse, Mich ^c   Law, Barbara ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Brighton Collaboration anaphylaxis case definition; Case study; Checklists; Immunization safety

Indexed keywords

VACCINE;

ANAPHYLAXIS; ARTICLE; CASE STUDY; CHECKLIST; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; MEDICAL RECORD; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; CHEMICALLY INDUCED; PREVENTIVE HEALTH SERVICE; STANDARDS; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; CHECKLIST; HUMANS; IMMUNIZATION PROGRAMS; VACCINATION; VACCINES;

EID: 77953028312     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.041     Document Type: Article

References (13)

1. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25 (2007) 5671-5674
2. http://www.brightoncollaboration.org [last accessed 25 June 2009].
3. Bonhoeffer J., Bentsi-Enchill A., Chen R., Fischer M.C., Gold M.S., Hartman K., et al. Guidelines for the collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine 27 (2009) 2289-2297
4. Bonhoeffer J., Bentsi-Enchill A., Chen R., Fischer M.C., Gold M.S., Hartman K., et al. Guidelines for the collection, analysis and presentation of vaccine safety data in clinical trials. Vaccine 27 (2009) 2282-2288
5. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 May (5) (2004) 832-836
6. Rüggeberg J.U., Gold M.S., Bayas J.M., Blum M.D., Bonhoeffer J., Friedlander S., et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2007) 5675-5684
7. Sejvar J.J., Kohl K.S., Bilynsky R., Blumberg D., Cvetkovich T., Galama J., et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 25 (2007) 5771-5792
8. Simons F.E., Frew A.J., Ansotegui I.J., Bochner B.S., Golden D.B., Finkelman F.D., et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120 1 Suppl. (2007) S2-S24
9. Urticaria. In: Miescher P.A., and Müller-Eberhard H.J. (Eds). Textbook of immunopathology. 2nd ed. (1976), Grune and Stratton, New York
10. http://www.diseasesdatabase.com/begin.asp?gif=1 (last accessed October 10, 2009).
11. Sampson H.A., Furlong A., Campbell R.L., Adkinson N.F., Bock A.S., Branum A., et al. Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
12. Physical examination. In: Don M., Roberton M.J., and South (Eds). Practical paediatrics. 6th ed. (2007), Elsevier Health Sciences
13. www.nlm.gov/MEDLINEPLUS/ency/article/003060.htm (last accessed October 10, 2009).